ustransplant Home | Contact us | Site Map
Program and OPO Specific Reports , January 2010


Comments submitted by program:

Comments General Comments About This Program
University of California at Los Angeles Medical Center, Los Angeles, CA X

General Comments:

This report represents a snapshot summary of the liver transplant programs at the Dumont-UCLA Transplant Center from July 1, 2008 to June 30, 2009. It is important to note that different cohorts or groups of patients were included in the analysis for the various portions of the tabular analysis. Advanced statistical techniques were used to create comparisons between specific data for our center and pooled data for other centers in our region and the nation. UCLA Liver Transplant Program remains one of the busiest centers (if not the busiest) in the United States and serves as quaternary referral transplant center in our region and nationally. As such, UCLA performs cadaveric liver transplantation on patients who are sicker or have higher acuity of illness compared to other centers in the country. Despite these factors, UCLA has patient and graft survival outcomes that clearly fall within the expected range and do not differ significantly from outcomes seen nationally in less acutely ill patients.
X

General Comments:

This report represents a snapshot summary of the liver transplant programs at the Dumont-UCLA Transplant Center from July 1, 2008 to June 30, 2009. It is important to note that different cohorts or groups of patients were included in the analysis for the various portions of the tabular analysis. Advanced statistical techniques were used to create comparisons between specific data for our center and pooled data for other centers in our region and the nation. UCLA Liver Transplant Program remains one of the busiest centers (if not the busiest) in the United States and serves as quaternary referral transplant center in our region and nationally. As such, UCLA performs cadaveric liver transplantation on patients who are sicker or have higher acuity of illness compared to other centers in the country. Despite these factors, UCLA has patient and graft survival outcomes that clearly fall within the expected range and do not differ significantly from outcomes seen nationally in less acutely ill patients.

Program Summary
Center: University of California at Los Angeles Medical Center (CAUC)
Organ: LI: Liver
             
  Center Activity (07/01/2008-06/30/2009) Center Region United States   Tables for More Information
Deceased donor transplants (n=number) 208 848 6,071 07C,08C,09C
Living donor transplants (n) 5 39 230 07L,08L,09L
On waitlist at start (n) 573 4,109 16,549 01,02,03
On waitlist at end (n) 541 3,993 16,351 01,02
  Number of new patient registrations (n) 389 1,951 11,089   01,02
  Waiting List Outcomes ( 07/01/2008-06/30/2009)   Tables for More Information
    Observed Expected Statistical Significance of Difference    
Transplant rate among waitlist patients 0.40 0.56 Statistically Lower (b) 03,04,05,06
Transplant rate (from deceased donors) among waitlist patients 0.40 0.55 Statistically Lower (b) 03,04,05,06
  Mortality rate while on waitlist 0.16 0.13 Statistically Higher (b)   03,04
             
  Post-transplant Outcomes ( 07/01/2006-12/31/2008) 1 Year Tables for More Information
    Observed Expected Statistical Significance of Difference    
Adult graft survival (based on 474  transplants) (%) 78.29 80.35 Not Significantly Different (a) 10
Adult patient survival (based on 433  transplants) (%) 84.24 85.08 Not Significantly Different (a) 11
  Pediatric graft survival (based on 43  transplants) (%) 90.70 84.57 Not Significantly Different (a)   10
Pediatric patient survival (based on 35  transplants) (%) 100.00 92.52 Not Significantly Different (a) 11
The data reported here were prepared by the Scientific Registry of Transplant Recipients (SRTR) under contract with the Health Resources and Services Administration (HRSA).
Note:  Tables referring to small sample sizes should be treated with caution.  Sample sizes can be found in the table referenced in the last column.
The SRTR is administered by the Arbor Research Collaborative for Health with the University of Michigan,
with oversight and funding from the Health Resources and Services Administration.

About the SRTR | National Transplant Statistics | Program and OPO Data | Research Resources | Privacy Statement
Spacer